Acute lymphoblastic leukaemia therapy in Poland. A report from the Polish Children's Leukaemia/Lymphoma Study Group

U Radwańska; D Michalewska; J Armata; W Balwierz; J Bogusławska-Jaworska; R Cyklis; D Derulska; P Kołecki; M Lastowska; T Newecka-Samól

Acute lymphoblastic leukaemia therapy in Poland. A report from the Polish Children's Leukaemia/Lymphoma Study Group

Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(2):199-210.

Authors

U Radwańska¹, D Michalewska, J Armata, W Balwierz, J Bogusławska-Jaworska, R Cyklis, D Derulska, P Kołecki, M Lastowska, T Newecka-Samól, et al.

Affiliation

¹ University School of Medicine in Poznań, Poland.

PMID: 2475398

Abstract

Treatment results of 1304 children with ALL obtained in Poland are presented. A group of 524 patients has been subject to a detailed analysis. These patients have been treated in the years 1981-1985 according to the BFM Protocol. In this group the 6-years CCR probability amounts to 0.56.

Publication types

Clinical Trial
Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Child
Child, Preschool
Clinical Trials as Topic
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Male
Poland
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
Remission Induction